WST West Pharma Company Net Income

WST (West Pharmaceutical Services, Inc.) - company brandmark

While West Pharmaceutical Services (WST) extracts superprofits from the GLP-1 drug boom, its status as the invisible foundation of medicine ensures colossal trust from pharma giants. The company's financial performance dynamics on the GURU.Markets portal confirm this growth, where 0.63 reflects the baseline level of the metric. Stringent FDA certifications cement the brand's monopoly in the sterile packaging sector, creating an unsurpassed barrier for competitors.

WST (West Pharmaceutical Services) Net Profit history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company West Pharmaceutical Services, Inc. (WST)

- market value and analyst target forecast:
Stock Price West Pharma Corp|WST - Price Target Chart
- market capitalization data:
Market Value West Pharma Corp|WST - Real Price to Acquire Entire Company
- book capitalization indicators:
Accounting Value of a Share West Pharmaceutical Services|WST - Book Capitalization|Market Capitalization to Book Value westpharma.com|WST - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio West Pharmaceutical Services|WST - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient West Pharma|WST - Company Total Debt|Debt to Book Capital West Pharma Corp|WST - Company Long-Term Debt|Company Short-Term Loans and Borrowings West Pharmaceutical Services|Quick Ratio westpharma.com
- net income and valuation multiples indicators:
WST - Company Net Income
Summary company analysis:West Pharma Corp - WST
Brand item of West Pharmaceutical Services Inc

Steady demand for certified injectable packaging creates a foundation of financial stability for West Pharmaceutical Services. The company's bottom line reflects the conversion of this operational advantage into real capital. This metric captures the remaining funds after deducting all operating expenses, taxes, and liabilities. Positive momentum confirms the effectiveness of the "cash cow" business model. This indicator allows investors to determine the fair value of the asset.

Main competitors

Intuitive Corp (ISRG) - Net Profit|Company Net Income Danaher Corp.|Company Net Income BDX|Net Income STE (STERIS)|BAX (Baxter International Inc.) - Final Profit|Net Profit MASI (Masimo Personal Health)|Net Financial Result Stevanato Group Corp (STVN)|TFX - Company Net Income|MMSI (merit.com) - Company Profit|Envista (NVST) - Company Net Income|ICUI - Net Financial Result|Net Income XRAY|LMAT (LeMaitre Corp) - Profit After Payment of Taxes|Company Net Income AtriCure, Inc. (ATRC)|STAA (staar.com) - Final Profit|ChromaDex Corp - Net Income|Net Profit ZimVie Inc ZIMV|ANGO - Company Net Income|Cerus Inc (CERS) - Net Income|TKNO: Net Profit|Company Net Income monogramorthopedics.com (MGRM)|Company Net Income Sharps Technology Inc|Company Profit INFU (InfuSystem Inc)|Net Income UTMD (Utah Medical)|Profit After Payment of Taxes KRMD|Company Net Income Nyxoah S.A. NYXH|Net Financial Result microbotmedical.com (MBOT)|PDEX: Net Income|Zentek Ltd (ZTEK) - Net Income|ELUT: Net Profit|Company Net Income Milestone Scientific Corporation (MLSS)|Company Net Income NEXGEL, Inc.|Retractable Tech (RVP) - Net Financial Result|Net Income HBIO (Harvard Bioscience, Inc.)|Profit After Payment of Taxes FEMY|Meihua Medical Technologies Co., Ltd. - Net Income|Final Profit POAI|CJMB - Company Net Income|Profit After Tax ATRI|NURO: Net Profit